Oxford Medical Case Reports · Published 2026-05-27 · DOI 10.1093/omcr/omag079
Carolina Barbosa Carvalho do Carmo, Ana Luiza Potiguara de Sousa, Gabriel Henrique de Souza Alves Glória, Isabella Serpa Andrade Borges, Alesso Cervantes Sartorelli, Alexandre Nonino
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Carmo, C., Sousa, A., Glória, G., et al. (2026). Rosai–Dorfman disease with MAP2K1 mutation: therapeutic response to MEK inhibition after failure of conventional therapy. Oxford Medical Case Reports. https://doi.org/10.1093/omcr/omag079